Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

University of Toronto

$70,000.00

Tumor Necrosis Factor Receptor Associated Factor single nucleotide polymorphisms as correlates of progression for HIV infection and CD8 T cell responsiveness to costimulatory rescue signals

FY 2009-10

Summary
A healthy human immune system produces a special type of white blood cell called a killer T cell. In a normal viral infection, these killer T cells are able to recognize and eliminate virus particles, and although we may get sick, the infection is short-lived and eventually eliminated. However, some viruses are unable to be completely cleared by the immune system, leading to a chronic infection. Such is the situation in Human Immunodeficiency Virus (HIV) infections. In this case, killer T cells can become exhausted from constantly fighting the HIV infection. Over time, they lose their ability to keep virus replication in check, leading to disease progression. Although several factors are important for killer T cells to respond to infections, we have found the amount of one particular molecule, called TRAF1, varies depending on the stage of the HIV infection. Different individuals have different versions of the gene which encodes for TRAF1 and other TRAFs, and this may account for why some HIV-infected patients progress quickly to AIDS, which others display no symptoms for several years post-infection. In this project, we hope to determine whether quickly-progressing patients are more likely to have a particular version of certain TRAF genes compared to slow-progressing HIV patients. In addition, if differences in TRAF genes are responsible for killer T cell exhaustion in HIV infection, we may be able to counteract the exhaustion therapeutically by providing the cells with survival and proliferation signals. Identifying the version of TRAF genes possessed by an HIV-infected individual may help health professionals to predict the rate of disease progression and make informed decisions regarding the best treatment strategies.
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
206235
Name
Wagar Lisa E
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Tumor Necrosis Factor Receptor Associated Factor single nucleotide polymorphisms as correlates of progression for HIV infection and CD8 T cell responsiveness to costimulatory rescue signals
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$70,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Correlates Of Progression; Genetic Polymorphisms; Human Immunodeficiency Virus (Hiv); Human Immunology; T Cell Costimulation
Abstract
A healthy human immune system produces a special type of white blood cell called a killer T cell. In a normal viral infection, these killer T cells are able to recognize and eliminate virus particles, and although we may get sick, the infection is short-lived and eventually eliminated. However, some viruses are unable to be completely cleared by the immune system, leading to a chronic infection. Such is the situation in Human Immunodeficiency Virus (HIV) infections. In this case, killer T cells can become exhausted from constantly fighting the HIV infection. Over time, they lose their ability to keep virus replication in check, leading to disease progression. Although several factors are important for killer T cells to respond to infections, we have found the amount of one particular molecule, called TRAF1, varies depending on the stage of the HIV infection. Different individuals have different versions of the gene which encodes for TRAF1 and other TRAFs, and this may account for why some HIV-infected patients progress quickly to AIDS, which others display no symptoms for several years post-infection. In this project, we hope to determine whether quickly-progressing patients are more likely to have a particular version of certain TRAF genes compared to slow-progressing HIV patients. In addition, if differences in TRAF genes are responsible for killer T cell exhaustion in HIV infection, we may be able to counteract the exhaustion therapeutically by providing the cells with survival and proliferation signals. Identifying the version of TRAF genes possessed by an HIV-infected individual may help health professionals to predict the rate of disease progression and make informed decisions regarding the best treatment strategies.
Competitiondate
200910
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Wagar, Lisa E
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $70,000~ $0~